ENTITY
Suzhou Zelgen Biopharmaceutica

Suzhou Zelgen Biopharmaceutica (688266 CH)

20
Analysis
Health CareChina
Suzhou Zelgen Biopharmaceuticals Co., Ltd. researches, develops, manufactures, and sells new medications. The Company provides small molecule targeted drugs, recombinant protein drugs, and other treatments of cancer, blood diseases, hepatobiliary diseases, and more. Suzhou Zelgen Biopharmaceuticals markets its drugs domestically.
more
Refresh
bullishSICC
25 Oct 2022 04:50

STAR50 Index Rebalance Preview: Stable Long/Short Performance in a Volatile Market

We expect the index committee to continue using a 6-month minimum listing history. That means 5 changes in December. The potential adds have...

Logo
525 Views
Share
13 Sep 2022 01:25

STAR50 Index Rebalance Preview: Four or Five Changes in December

There could be 4/5 changes if a 12/6 month minimum listing history is used. Using a 6 month minimum listing history, one-way turnover is estimated...

Logo
475 Views
Share
27 Aug 2022 09:34

STAR50 Index Rebalance: Adds Continue to Outperform as Changes Are Announced

There are 5 changes to the STAR50 in September as the index committee sticks to a 6 month minimum listing history. The adds have outperformed the...

Logo
558 Views
Share
20 Jul 2022 05:13

STAR50 Index Rebalance Preview (Sep): Adds Outperforming the Deletes

There could be 5 changes if the index committee continues using a 6 month minimum listing history. The adds have outperformed the deletes over the...

Logo
523 Views
Share
09 Jun 2022 06:11

STAR50 Index Rebalance Preview (Sep): Change Is the Only Constant

We expect the index committee to continue using a 6 month minimum listing history and that will lead to 5 changes in September. Buying the adds and...

Logo
490 Views
Share
x